Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15010 total
Seagate Technology Holdings enters the final stretch before its July 23 earnings print having surrendered 14% in a week — yet with the analyst community refusing to blink. The price action is the story this week. STX…
DigitalOcean enters the final stretch before its August 4 earnings report with a notable divergence: short sellers are quietly unwinding while institutional money flows in — yet the stock has shed nearly 20% in a…
Leonardo DRS enters its July 30 earnings window with shorts steadily unwinding, options traders leaning constructively, and the Street's analyst community holding a largely positive view — the tension worth watching is…
Coinbase Global finds itself in a curious position this week: the stock has bounced hard while short sellers have quietly trimmed exposure — yet options traders remain more defensive than usual, and the Street's price…
Valaris heads into its July 30 earnings with a fresh analyst cut landing on a stock that has lost 16% in a month, yet short sellers appear to be quietly covering rather than pressing the trade. The most significant…
Hims & Hers Health heads into the week before its August 3 earnings with the short position still enormous but the acute squeeze pressure of late June clearly unwinding. The lending market has shifted meaningfully…
AFRM heads into the week after a strong month with an unusual dynamic: the analyst community is moving more constructively just as short sellers trim exposure, yet options traders are edging more defensive — leaving…
RGC enters the week with its lending pool nearly exhausted — a condition that has persisted for days and is now intensifying as short interest accelerates sharply higher. The borrow story is the dominant angle here.…
PROG Holdings enters the final stretch before its July 29 earnings report with the Street sharply divided — and a fresh, high-conviction analyst upgrade arriving just as the stock pulls back from its recent highs. The…
MediaAlpha enters the week after a 50% one-month surge with an unusual split: the Street just turned more bullish, insiders are using the run-up to sell, and options traders are the least defensive they have been all…
OPEN enters the second week of July with its bear camp dug in — short interest has barely moved from the multi-month high set last week, the CEO is buying into the weakness, and earnings are five weeks away. The short…
Immunome heads into the week with a striking split: the stock is up 15% in five days, but insiders are selling into every uptick while short sellers are holding their ground. The insider activity tells the most urgent…
WillScot Holdings enters the week before its August 3 earnings in an unusual position: a fresh analyst upgrade arrived the same day the stock fell 3% to $25.67, capping an 11% weekly decline that has pushed the shares…
Lemonade heads into its July 29 earnings with a sharp analyst downgrade landing on the same day the stock trades 50% above where it was just one month ago. The most significant development this week is Morgan Stanley's…
CMPS heads into the week of July 8 with a wave of bullish analyst action reshaping the Street narrative — even as the stock pulls back 8% on the week and earnings loom on July 30. The analyst story is the standout this…
KC enters the week with a rare combination: a fresh Morgan Stanley initiation on the bull side and a borrow market that has been running near capacity for over a month. The most significant development this week is the…
Accel Entertainment enters its July 30 earnings print with a quiet but persistent build in short positions and a cluster of insider sales that together create a more cautious backdrop than the modestly positive monthly…
Definium Therapeutics has pulled back 5.4% this week to $44.48, giving back a slice of the 89% one-month gain that followed its June 22 Phase 3 data release — and the question now is whether the defensive posture…
Arcutis Biotherapeutics has climbed 30% in a month and nearly 6% in a week, yet nearly 13% of the float remains short — a setup where the stock's momentum and its skeptics are heading in opposite directions ahead of a…
Betterware de México heads into its July 23 Q2 earnings report with the Street uniformly constructive, the borrow market loose, and a historically painful pattern from last quarter still fresh. The earnings setup is…
